173 related articles for article (PubMed ID: 28274142)
1. Stem cell therapy for the treatment of Peyronie's disease.
Dellis A; Papatsoris A
Expert Opin Biol Ther; 2017 Apr; 17(4):407-413. PubMed ID: 28274142
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease.
Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Kim H; Trost LW; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
Andrology; 2014 Mar; 2(2):244-51. PubMed ID: 24574095
[TBL] [Abstract][Full Text] [Related]
3. Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis.
Gokce A; Abd Elmageed ZY; Lasker GF; Bouljihad M; Braun SE; Kim H; Kadowitz PJ; Abdel-Mageed AB; Sikka SC; Hellstrom WJ
J Sex Med; 2015 Jul; 12(7):1533-44. PubMed ID: 26062100
[TBL] [Abstract][Full Text] [Related]
4. Advances in stem cell therapy for erectile dysfunction.
Gur S; Abdel-Mageed AB; Sikka SC; Hellstrom WJG
Expert Opin Biol Ther; 2018 Nov; 18(11):1137-1150. PubMed ID: 30301368
[TBL] [Abstract][Full Text] [Related]
5. Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? Eur Urol 2013;63:561-2: Xenogeneic Adipose Stem Cell Treatment in a Rat Model of Peyronie's Disease.
Castiglione F; Hedlund P; Van der Aa F; Bivalacqua TJ; Rigatti P; Van Poppel H; Montorsi F; De Ridder D; Albersen M
Eur Urol; 2013 Mar; 63(3):563-4. PubMed ID: 23265388
[No Abstract] [Full Text] [Related]
6. Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie's Disease.
Milenkovic U; Ilg MM; Cellek S; Albersen M
Sex Med Rev; 2019 Oct; 7(4):679-689. PubMed ID: 30962046
[TBL] [Abstract][Full Text] [Related]
7. [Stem cells for the treatment of Peyronie's disease].
Zhao F; Huang YQ; Ma LM
Zhonghua Nan Ke Xue; 2021 Sep; 27(9):840-844. PubMed ID: 34914262
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
Chang KA; Lee JH; Suh YH
J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
[TBL] [Abstract][Full Text] [Related]
9. Peyronie's disease: a review.
Gholami SS; Gonzalez-Cadavid NF; Lin CS; Rajfer J; Lue TF
J Urol; 2003 Apr; 169(4):1234-41. PubMed ID: 12629334
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in Peyronie's disease.
Gonzalez-Cadavid NF; Magee TR; Ferrini M; Qian A; Vernet D; Rajfer J
Int J Impot Res; 2002 Oct; 14(5):361-74. PubMed ID: 12454687
[TBL] [Abstract][Full Text] [Related]
11. [Animal models of Peyronie's disease: An update].
Li JH; Yuan JH
Zhonghua Nan Ke Xue; 2016 May; 22(5):446-9. PubMed ID: 27416671
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms and potential of stem cell therapy for penile fibrosis.
Milenkovic U; Albersen M; Castiglione F
Nat Rev Urol; 2019 Feb; 16(2):79-97. PubMed ID: 30367131
[TBL] [Abstract][Full Text] [Related]
13. Management of Peyronie's disease--a review.
Tunuguntla HS
World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Platelet-Rich Plasma on Peyronie's Disease in Rat Model.
Culha MG; Erkan E; Cay T; Yücetaş U
Urol Int; 2019; 102(2):218-223. PubMed ID: 30317233
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
16. Stem-cell regenerative medicine as applied to the penis.
Pozzi E; Muneer A; Sangster P; Alnajjar HM; Salonia A; Bettocchi C; Castiglione F; Ralph DJ;
Curr Opin Urol; 2019 Jul; 29(4):443-449. PubMed ID: 31008782
[TBL] [Abstract][Full Text] [Related]
17. Adipose-derived stem cells for the treatment of Peyronie's disease?
Lin CS; Lue TF
Eur Urol; 2013 Mar; 63(3):561-2. PubMed ID: 23149148
[No Abstract] [Full Text] [Related]
18. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
Strebel RT; Suter S; Sautter T; Hauri D
Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
[TBL] [Abstract][Full Text] [Related]
20. Penile sonographic and clinical characteristics in men with Peyronie's disease.
Smith JF; Brant WO; Fradet V; Shindel AW; Vittinghoff E; Chi T; Huang YC; Davis CB; Conti S; Lue TF
J Sex Med; 2009 Oct; 6(10):2858-67. PubMed ID: 19732312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
